BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 184 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,880,000 | -81.9% | 455,000 | +74.5% | 0.36% | -46.0% |
| Q2 2020 | $15,913,000 | -44.4% | 260,700 | -58.1% | 0.67% | -45.4% |
| Q1 2020 | $28,597,000 | -52.1% | 622,210 | -8.6% | 1.22% | -42.6% |
| Q4 2019 | $59,708,000 | +28.2% | 680,430 | +34.2% | 2.13% | +21.0% |
| Q3 2019 | $46,561,000 | -0.6% | 507,090 | +37.8% | 1.76% | -3.1% |
| Q2 2019 | $46,821,000 | -1.7% | 368,090 | +21.5% | 1.82% | -5.6% |
| Q1 2019 | $47,654,000 | – | 302,890 | – | 1.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |